Skip to main content
. 2017 Aug 8;32(9):1846–1854. doi: 10.1093/humrep/dex237

Table I.

Baseline characteristics of 300 women (313 unique FFQs) in the EARTH study (2007–2015) according to alcohol and caffeine intakes.

Categories of alcohol intake (g/day) Categories of caffeine intake (mg/day)
Median 0.0 2.34 8.67 15.46 32.37 11.9 65.3 123.9 252.0 370.6
Range 32 0.1, 6.0 6.1, 12.0 12.1, 24.0 24.1, 85.8 0.31, 50 50.1, 100 100.1, 200 200.1, 300 300.1, 642
Unique FFQs, N 54 127 63 72 19 93 48 99 56 17
Cycles, N 195 106 106 32 156 65 151 93 28
Baseline characteristics
 Age, years Mean ± SD 34.4 ± 4.9 35.6 ± 4.4 34.2 ± 5.6 34.9 ± 3.1 37.9 ± 3.4 35.3 ± 4.0 35.7 ± 4.8 34.4 ± 5.3 35.3 ± 3.6 36.6 ± 3.3
 White/Caucasian, N (%) 23 (71.9) 103 (81.1) 59 (93.7) 63 (87.5) 16 (84.2) 74 (79.6) 33 (68.8) 88 (88.9) 52 (92.9) 17 (100.0)
 BMI, kg/m2 Mean ± SD 24.3 ± 5.4 24.2 ± 4.2 23.9 ± 3.4 23.8 ± 4.0 25.2 ± 3.8 23.5 ± 4.2 24.5 ± 3.7 23.8 ± 4.1 24.9 ± 3.9 25.8 ± 5.3
 Smoking status, N (%)
  Never smoker 26 (81.3) 96 (75.6) 44 (69.8) 48 (66.7) 10 (52.6) 75 (80.7) 38 (79.2) 69 (69.7) 35 (62.5) 7 (41.2)
  Former smoker 6 (18.8) 29 (22.8) 19 (30.2) 20 (27.8) 8 (42.1) 18 (19.4) 10 (20.8) 29 (29.3) 17 (30.4) 8 (47.1)
  Current smoker 0 (0.0) 2 (1.6) 0 (0.0) 4 (5.6) 1 (5.3) 0 (0.0) 0 (0.0) 1 (1.0) 4 (7.1) 2 (11.8)
 College degree or higher, N (%) 27 (87.1) 114 (91.2) 57 (91.9) 64 (92.8) 16 (88.9) 85 (92.4) 41 (91.1) 88 (90.7) 50 (92.6) 14 (82.4)
Dietary characteristics
 Caffeine intake, mg/day Mean ± SD 78.1 ± 72.9 102.1 ± 108.6 159.3 ± 127.4 136.6 ± 86.0 192.3 ± 102.4 19.3 ± 14.7 73.0 ± 16.1 128.8 ± 23.7 252.3 ± 26.3 401.0 ± 106.5
 Alcohol intake, g/day Mean ± SD 0.0 ± 0.0 2.5 ± 1.6 8.8 ± 1.7 16.1 ± 2.7 38.5 ± 16.9 4.5 ± 5.1 7.7 ± 9.9 11.8 ± 13.1 10.8 ± 10.9 11.5 ± 8.1
 Calorie intake, kcal/day Mean ± SD 1604.7 ± 571.5 1682.5 ± 608.4 1858.6 ± 558.3 1901.9 ± 587.5 2235.5 ± 572.1 1712.4 ± 604.4 1671.5 ± 551.0 1871.0 ± 673.4 1786.9 ± 504.8 2162.6 ± 464.5
 Dietary folate equivalents, mcg/day  Mean ± SD 1530.3 ± 660.3 1887.2 ± 888.0 1844.2 ± 819.7 1846.2 ± 800.0 1602.1 ± 673.2 1795.1 ± 850.2 1957.4 ± 976.5 1744.2 ± 721.8 1770.0 ± 748.9 2088.3 ± 1006.7
 Vitamin B12, mcg/day Mean ± SD 9.9 ± 3.9 34.4 ± 97.6 46.3 ± 121.7 28.6 ± 83.5 37.3 ± 113.9 32.0 ± 88.9 54.8 ± 139.0 17.1 ± 51.2 29.7 ± 93.5 82.6 ± 161.2
 Prudent pattern score Mean ± SD −0.55 ± 0.82 −0. 21 ± 0.93 0.12 ± 1.01 0.16 ± 1.07 0.44 ± 0.99 −0.19 ± 0.92 −0.24 ± 0.77 0.15 ± 1.18 −0.09 ± 1.00 0.15 ± 0.76
 Western pattern score Mean ± SD −0.04 ± 0.88 −0.16 ± 0.95 0.02 ± 0.80 0.10 ± 0.96 0.54 ± 1.15 −0.08 ± 0.96 −0.07 ± 0.94 0.01 ± 0.91 0.04 ± 0.92 0.27 ± 1.09
Partner characteristics
 Age, years Mean ± SD 35.7 ± 4.4 36.5 ± 4.7 37.2 ± 6.5 36.5 ± 3.7 38.0 ± 6.2 37.6 ± 5.5 36.5 ± 6.3 35.6 ± 4.3 36.5 ± 4.3 38.2 ± 3.9
 BMI, kg/m2 Mean ± SD 26.9 ± 3.4 27.5 ± 4.4 26.7 ± 3.5 26.6 ± 3.8 28.4 ± 2.6 26.8 ± 4.0 26.9 ± 3.3 26.9 ± 4.1 27.9 ± 4.0 28.4 ± 3.9
 Ever smoker, N (%) 8 (42.1) 15 (20.3) 15 (38.5) 15 (36.6) 7 (63.6) 12 (22.6) 11 (36.7) 17 (28.8) 18 (51.4) 2 (28.6)
 Caffeine intake, mg/day Mean ± SD 224.4 ± 174.1 194.9 ± 124.8 216.4 ± 126.5 176.1 ± 112.4 225.2 ± 125.8 168.2 ± 127.4 229.9 ± 153.5 199.4 ± 134.0 219.6 ± 199.0 219.6 ± 116.4
 Alcohol intake, g/day Mean ± SD 6.0 ± 9.4 10.7 ± 10.0 16.9 ± 9.8 22.0 ± 14.4 21.9 ± 13.6 11.8 ± 10.8 15.5 ± 11.7 15.5 ± 11.8 17.0 ± 15.4 17.0 ± 15.5
Reproductive characteristics
 Initial infertility diagnosis, N (%)
  Male factor 12 (37.5) 43 (33.9) 17 (27.0) 21 (29.2) 9 (47.4) 29 (31.2) 20 (41.7) 30 (30.3) 18 (32.1) 5 (29.4)
  Diminished ovarian reserve 2 (6.2) 14 (11.0) 4 (6.3) 2 (2.8) 1 (5.3) 8 (8.6) 6 (12.5) 5 (5.0) 1 (1.8) 3 (17.6)
  Endometriosis 5 (15.6) 4 (3.1) 1 (1.6) 2 (2.8) 2 (10.5) 6 (6.4) 2 (4.2) 2 (2.0) 4 (7.1) 0 (0.0)
  Ovulatory 2 (6.2) 11 (8.7) 5 (9.7) 11 (15.3) 0 (0.0) 5 (5.4) 6 (15.5) 11 (11.1) 5 (8.9) 2 (11.8)
  Tubal 4 (12.5) 6 (4.7) 3 (4.8) 9 (12.5) 2 (10.5) 6 (6.4) 3 (6.2) 8 (8.1) 6 (10.7) 1 (6.0)
  Uterine 0 (0.0) 0 (0.0) 3 (4.8) 1 (1.4) 1 (5.3) 0 (0.0) 0 (0.0) 3 (3.0) 0 (0.0) 2 (1.8)
  Unexplained 7 (21.9) 49 (38.6) 30 (47.6) 26 (36.1) 4 (21.1) 39 (41.9) 11 (22.9) 40 (40.4) 22 (39.3) 4 (23.5)
 Initial treatment protocol, N (%)
  Antagonist 6 (18.7) 13 (10.2) 5 (7.9) 9 (12.5) 3 (15.8) 14 (15.1) 3 (6.3) 8 (8.1) 8 (14.3) 3 (17.7)
  Flare 3 (9.4) 15 (11.8) 5 (7.9) 8 (11.1) 4 (21.1) 11 (11.8) 7 (14.6) 9 (9.1) 6 (10.7) 2 (11.8)
  Luteal phase agonist 23 (71.9) 99 (78.0) 53 (84.1) 55 (76.4) 12 (63.2) 68 (73.1) 38 (79.2) 82 (82.8) 42 (75.0) 12 (70.6)
 Day three FSH, IU/L mean ± SD 7.31 ± 2.15 7.49 ± 3.12 7.21 ± 2.28 6.85 ± 1.89 7.84 ± 2.07 7.42 ± 2.50 7.81 ± 3.44 6.99 ± 2.53 7.14 ± 1.78 7.28 ± 2.37
 Previous IVF at MGH, N (%) 12 (37.5) 30 (23.6) 18 (28.6) 14 (19.4) 3 (15.8) 26 (28.0) 15 (31.2) 23 (23.2) 10 (17.9) 3 (17.6)
 Previous IUI at MGH, N (%) 11 (34.4) 53 (41.7) 24 (38.1) 31 (43.1) 3 (15.8) 42 (45.2) 20 (41.7) 38 (38.4) 18 (32.1) 4 (25.5)

EARTH: Environment and Reproductive Health; FFQ: Food Frequency Questionnaire; MGH: Massachusetts General Hospital.